The Canadian Journal of Diabetes is Canada's only diabetes-oriented, peer-reviewed, interdisciplinary journal for diabetes healthcare professionals. The Canadian Journal of Diabetes is the official publication of the Clinical and Scientific Section and the Diabetes Educators Section of the Canadian Diabetes Association (CDA). Published bimonthly Canadian Journal of Diabetes contains original articles, reviews, and shorter articles such as Perspectives in Practice, and Diabetes and Society.

The mission of Canadian Journal of Diabetes is to promote the sharing of interdisciplinary research and evidence-based knowledge, from basic or clinical science to public health and education, which leads to advances in the care of diabetes.

Canadian Journal of Diabetes invites submission on matters relevant to the practice of diabetes care and education. Submit manuscripts online at http://ees.elsevier.com/cjd/.

The submission requirements are in accordance with the "Uniform requirements for manuscripts submitted to biomedical journals" (JAMA 1997;277:927-34). Canadian Journal of Diabetes uses the AMA Manual of Style: A Guide for Authors and Editors 10th Edition for editorial style.

ETHICS

Work on human beings that is submitted to the journal should comply with the principles laid down in the Declaration of Helsinki "Recommendations guiding physicians in biomedical research involving human subjects", adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964 (and its successive amendments). The manuscript should contain a statement that the work has been approved by the appropriate ethical committees related to the institution(s) in which it was performed. Studies involving experiments with animals must state that their care was in accordance with institution guidelines.

Patients and Study Participants
Studies on patients or volunteers require ethics committee approval and informed consent which should be documented in your paper.

Patients have a right to privacy. Therefore identifying information, including patient's photographs, pedigree, images, names, initials, or hospital numbers, should not be included in the submissions unless the information is essential for scientific purposes and written informed consent has been obtained for publication in print and electronic form from the patient (or parent, guardian or next of kin). If such consent is made subject to any conditions, Elsevier must be made aware of all such conditions. Written consents must be provided to the journal on request.

Even where consent has been given, identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and editors should so note.

Clinical Trials
* All randomised controlled trials submitted to Canadian Journal of Diabetes whose primary purpose is to affect clinical practice (phase 3 trials) must be registered in accordance with the principles outlined by the International Committee of Medical Journal Editors (ICMJE; http://www.icmje.org/). ICMJE-approved registries currently include the following: http://www.anzctr.org.au, http://www.clinicaltrials.gov, http://www.ISRCTN.org, http://www.umin.ac.jp/ctr/index/htm, http://www.trialregister.nl, and https://eudract.ema.europa.eu/. Please include the unique trial number and registry name on manuscript submission.

MANUSCRIPT CATEGORIES

Original Research/Review Articles
Full-length articles report basic science and clinical investigation in areas relevant to diabetes. They may take the form of an Original Research or a Review article. Authors of basic science papers should take care to clearly establish the link of the work to diabetes, keeping in mind the broad readership of the journal by healthcare providers. Original Research articles must include a structured abstract and references. Review articles must also include an abstract (although it need not be structured) and should provide answers to clinically relevant questions that have not been well-answered to date or bring readers up to date on useful concepts in a rapidly changing field. Review articles should be organized in the same manner as Original Research papers. Full-length articles, including references, may be up to 5000 words. Reference list must not exceed 50 references.

Perspectives in Practice
This section provides a format for authors to discuss new programs or services, ideas, insights or practical approaches to diabetes care and education or professional development. Papers in this section should be well-referenced and follow the same format as a full-length research paper. Articles in this section should not exceed 2000 words in length.

Practical Diabetes
Articles under this section should be structured like review articles, well-referenced and focused on any aspect of the care of people with diabetes. Articles in this section should not exceed 2000 words in length.

Case Reports
The case report should outline a clinical situation that illustrates unique or atypical features or provides a lesson to be learned. Case reports should include an abstract, an introduction, and a brief and clear description of the case and comments including relevance, implications and recommendations. Articles in this section should not exceed 1000 words in length.

Diabetes and Society
Diabetes and Society articles take the form of a shorter, newspaper-style column, on topics such as advocacy, politics of healthcare, social policy, etc., as they affect the person with diabetes. A few references (10-15) are acceptable. Articles in this section should not exceed 1400 words in length.

Editorial Commentaries
Editorial Commentaries are brief, critical articles on some aspect of diabetes care or an article that appears elsewhere in the journal. Commentaries should include a statement of the issue or problem, an analysis of a few carefully selected findings citing supportive and counter-evidence and a summary statement that proposes a clear solution to the problem. Articles in this section should not exceed 700 words in length, with no more than 6 references.

Research Watch
Papers in this section take the form of short reports on relevant literature published in other journals. Journal articles appropriate for review will describe one of the following: research studies of interest to diabetes education or clinical practice; literature reviews on appropriate topics; reports of innovative education approaches; or administrative/quality management approaches for diabetes education and care programs.

Reviews will be of articles that are no more than 6 months old, and will contain a complete citation of the original article, including author credentials, a summary of the design and key findings, and comments on the clinical significance and implications of the work in relation to clinical diabetes education/care. Articles in this section should not exceed 900 words in length.

Innovations in Diabetes Care
Papers in this section review new resources relevant to the care and education of people with diabetes. They may comment on range and depth of contents, readability level, design, approach, price, and graphic elements. Articles in this section should not exceed 700 words in length.

Policies, Guidelines and Consensus Statements
Papers in this category will be solicited by the editorial staff of Canadian Journal of Diabetes as the need arises or opportunity presents.

MANUSCRIPT PREPARATION AND FORMAT

All materials (including tables) must be presented according to the following specifications:
• typed and double-spaced in Times New Roman 11pt font in Microsoft Word
• 1.0" margins on all sides
• page numbers in bottom right corner
• text flush left with no tabs
• line spaces to indicate paragraph breaks

Titles
Titles must be concisely worded and should be followed by:
• the name(s) of the author(s), with degrees
• each author's institutional affiliation, including city
• name, mailing address, telephone number, and e-mail address of corresponding author
• a word count, excluding abstract

Abstracts
Abstracts must have a maximum of 250 words, and include the paper's objective, method, results, conclusions and keywords. Original research articles must have a structured abstract.

Text
• Organize research papers under the following subheadings: Introduction, Methods, Results, Discussion, Acknowledgments, References, Tables, Table Legends, Figures, and Figure Legends.
• Organize all other papers under appropriate headings.
• Avoid the use of the term "diabetic" as a noun, use lower case for “diabetes” and use lower case for type 1/type 2.
• Use numerals in text rather than writing out numbers.
• Report all measurements in SI units.
• Report blood glucose in mmol/L.

Author Disclosures
Authors are asked to include in the manuscript a statement regarding conflicts of interest of all authors under the heading Author Disclosures.
All authors listed in the manuscript are required to submit a completed ICMJE Form for Disclosure of Potential Conflicts of Interest. All authors must disclose possible conflicts of interest at the time of submission. This information will remain confidential while the paper is under review and will not influence editorial decision. The information will be published with the article.

Author Contributions
Authors are asked to include in the manuscript a statement regarding the specific contributions of all authors to the preparation of the manuscript under the heading Author Contributions.
According to the International Committee of Medical Journal Editors, an author is someone who:
• "Contributed substantially to conception and design, or acquisition of data, or analysis and interpretation of data AND
• Drafted the article or revised it critically for important intellectual content AND
• Gave final approval of the version to be published."

References
• Number references consecutively in the order that they appear, using Arabic numerals in parentheses.
• Personal communications may appear in parentheses in the body of the paper, and are not to be included as references.
• Follow the AMA Manual of Style: A Guide for Authors and Editors 10th Edition.
• List three authors for a standard journal article; if the number of authors exceeds three, list the first three followed by "et al".

Example
Harris SB, Leiter LA, Yale JF, et al. Out-of-pocket costs of managing hyperglycemia and hypoglycemia in patients with type 1 diabetes and insulin-treated type 2 diabetes. Can J Diabetes 2007;31:25-33.

Tables and Figures
• Upload each figure or table as a separate file. Each file should be clearly identified.
• Ensure that information in charts and tables duplicates the text.
• Include written permission from publishers to reproduce previously published tables and illustrations.

Permissions
Written consent from the author and publisher of any submitted material previously published elsewhere must accompany the manuscript.

SUBMISSION

Submit manuscripts online at http://ees.elsevier.com/cjd/. To complete the submission you must include:
• cover letter - we would recommend including the names of 4 potential reviewers
• original manuscript in Microsoft Word
• figures and tables if required
• letter(s) of permission to reproduce material previously published elsewhere
• signed release for publication of identifiable subjects in photos and/or people acknowledged by name in the manuscript
• copyright release form, signed by all authors
• for each author a completed ICMJE Form for Disclosure of Potential Conflicts of Interest

COPYRIGHT INFORMATION

• Canadian Journal of Diabetes accepts original articles not previously published or currently submitted for publication in another journal.
• All authors must sign and submit the copyright release form for Canadian Journal of Diabetes.
• Manuscripts are accepted for review on the understanding that they are for publication solely in Canadian Journal of Diabetes.
• Published manuscripts become the property of the CDA. Permission to reprint the published manuscript in another publication must be obtained. For information on how to seek permission, visit http://www.elsevier.com/permissions.

Page Charges will not be made.

Offprints/Reprints. The corresponding author, at no cost, will be provided with a PDF file of the article. The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover image and a disclaimer outlining the terms and conditions of use. Paper offprints can be ordered by the authors. An order form with prices will be sent to the corresponding author.

Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors who publish in Elsevier journals to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies.